PATENT CLAIM ANALYSIS

Application Number: 15961419
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-05
Patent Classification: ["514", "253130"]

Abstract:
Treatment with 2-amino substituted nicotinamides or their salts ameliorates the cognitive and motor dysfunction associated with Angelman Syndrome (AS).

Claim (Index 22):
The method of  claim 18  wherein said testing is of a laboratory model and comprises the Hanging Wire test.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 91.0
- Lexical Diversity: 1.04762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15895881', '15702162', '15004218', '15869672', '13361720']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7381028909491278
- 35 USC 102 Novelty (BERT): 0.5143089835199003
- Combined Prediction Score: 0.7157235002062051
- Mean Citation Score: 149.459582
- Max Citation Score: 217.80348
- Similarity Product: 121.31247091258052

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test